echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cardiovasc diabetol: long-term cardiovascular outcomes of gestational diabetes

    Cardiovasc diabetol: long-term cardiovascular outcomes of gestational diabetes

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Previous studies have suggested that gestational diabetes may be a risk factor
    for subsequent atherosclerotic cardiovascular disease.
    However, there is limited
    information on different cardiovascular outcomes following gestational diabetes in older women.

    Recently, Cardiovasc Diabetol, an authoritative journal in the field of cardiovascular and metabolic diseases, published a research article in which researchers aimed to assess whether women with a history of gestational diabetes had an increased
    risk of long-term overall cardiovascular outcomes.

    Among the UK participants, the researchers included 219,330 women aged 40 to 69 who reported at least one live birth
    .
    The incidence
    of different cardiovascular outcomes was compared using a multivariate Cox proportional hazards model based on a history of gestational diabetes.
    In addition, the researchers performed causal-mediated analyses to assess the role of
    known risk factors in observing risk.

    After registration, 13,094 women (6.
    0%) experienced new global cardiovascular outcomes
    .
    Women with a history of gestational diabetes had an increased risk of overall cardiovascular outcomes [adjusted HR (aHR) 1.
    36 (95% CI 1.
    18 to 1.
    55)] after adjusting for age, race, BMI, smoking, early menopause, hysterectomy, epidemic disease, and medical therapy, including coronary artery disease [aHR 1.
    31 (1.
    08 to 1.
    59)], myocardial infarction [aHR 1.
    65 (1.
    27 to 2.
    15)], and ischaemic stroke [aHR 1.
    68].
    (1.
    18-2.
    39)], peripheral arterial disease [aHR 1.
    69 (1.
    14-2.
    51)], heart failure [aHR 1.
    41 (1.
    06-1.
    87)], mitral regurgitation [aHR 2.
    25 (1.
    51-3.
    34)], and atrial fibrillation/flutter [aHR 1.
    47 (1.
    18-1.
    84)].

    In mediated analyses, overt diabetes explained 23%, hypertension explained 11%, and dyslipidemia explained 10% of the association
    between gestational diabetes and overall cardiovascular outcomes.

    Gestational diabetes is associated with more diverse cardiovascular outcomes than previously thought, with traditional risk factors such as diabetes, hypertension and dyslipidemia contributing to some extent
    .

    Original source:

    Seung Mi Lee.
    et al.
    Long-term cardiovascular outcomes of gestational diabetes mellitus: a prospective UK Biobank study.
    Cardiovasc Diabetol.
    2022.
    https://cardiab.
    biomedcentral.
    com/articles/10.
    1186/s12933-022-01663-w

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.